By Market & Region

SHERIDAN, WYOMING – May 5, 2025 – Johnson & Johnson MedTech has marked a significant milestone in the evolution of robotic-assisted surgery by completing the first clinical trial cases of its OTTAVA™ Robotic Surgical System. This development positions the company at the forefront of innovation in minimally invasive procedures, reinforcing its strategic commitment to delivering cutting-edge surgical technologies that raise standards in operating rooms worldwide.

Strategic Leap in Robotic-Assisted Surgery

The inaugural clinical cases for the OTTAVA system were led by Dr. Erik Wilson, Chief of Minimally Invasive and Elective General Surgery at UT Health Houston, who performed Roux-en-Y gastric bypass surgeries at Memorial Hermann-Texas Medical Center. These procedures represent the first real-world clinical application of the OTTAVA system and a pivotal moment in its developmental journey.

SHERIDAN, WYOMING – May 5, 2025 – Shockwave Medical, Inc., a Johnson & Johnson MedTech company and global leader in circulatory restoration, has officially initiated its FORWARD CAD Investigational Device Exemption (IDE) study. This pivotal research effort will evaluate the safety and efficacy of the Shockwave Javelin Coronary IVL Catheter for the treatment of difficult-to-cross, heavily calcified coronary artery lesions—an area with high unmet clinical need and procedural risk.

The first patient in the study was successfully treated by Dr. Evan Shlofmitz and Dr. Ziad Ali at St. Francis Hospital & The Heart Center in Roslyn, New York. This milestone underscores the growing clinical interest in Shockwave’s forward IVL (intravascular lithotripsy) platform as a potential alternative to atherectomy, especially in complex percutaneous coronary interventions (PCI).

Advancing Treatment for Challenging Coronary Artery Disease

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for its Simplera Sync™ sensor, marking a significant expansion of its continuous glucose monitoring (CGM) portfolio in the United States. The approval enables integration of the Simplera Sync™ sensor with the company’s flagship MiniMed™ 780G system, offering greater flexibility and convenience to people managing diabetes through advanced insulin delivery technology.

Strategic Advancement in Diabetes Care Technology

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has officially submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) for its MiniMed™ 780G pump and SmartGuard™ algorithm, paving the way for seamless integration with Abbott’s advanced continuous glucose monitoring (CGM) platform. This critical regulatory milestone strengthens Medtronic’s strategic partnership with Abbott and positions the company to deliver more interoperable, intelligent diabetes care solutions to the U.S. market.

Accelerating Innovation Through Strategic Interoperability

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure™ defibrillation lead—the smallest-diameter, catheter-delivered defibrillation lead for right ventricular implantation. This approval marks a major advancement in cardiac rhythm management, offering physicians a less invasive, highly durable solution to treat life-threatening arrhythmias in both adults and adolescents with smaller anatomies.

Strategic Advancement in Cardiac Rhythm Management

The FDA’s green light for the OmniaSecure lead strengthens Medtronic’s leadership in electrophysiology and expands its robust portfolio of transvenous lead solutions. At only 4.7 French (1.6mm) in diameter, the OmniaSecure lead builds on the proven SelectSecure™ Model 3830 pacing lead platform, already widely adopted in the clinical community for over two decades.

SHERIDAN, WYOMING – May 5, 2025 – Medtronic has announced a major milestone for its Hugo™ robotic-assisted surgery (RAS) system, as the Expand URO U.S. clinical trial met both primary safety and effectiveness endpoints. The results position the company for strategic market entry into the U.S. robotic-assisted surgery sector, the largest of its kind globally, and were presented as a late-breaking session at the American Urologic Association (AUA) annual meeting in Las Vegas.

Landmark Trial Sets New Benchmark in Robotic Urologic Surgery

The Expand URO study is the largest Investigational Device Exemption (IDE) trial conducted in the U.S. for multi-port robotic-assisted urologic procedures. Designed as a prospective, multi-center, single-arm study, it involved 137 patients across six hospitals. Participants underwent one of three common urologic surgeries — prostatectomy, nephrectomy, or cystectomy — using the Hugo RAS system.

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT) has announced encouraging one-year clinical outcomes for its investigational Affera™ pulsed field ablation (PFA) technologies, reinforcing its strategic leadership in arrhythmia management. The results—revealed at the Heart Rhythm Society 2025 Annual Meeting—highlight the performance of the next-generation Sphere-360™ single-shot PFA catheter and the dual-energy Sphere-9™ catheter in treating patients with paroxysmal and persistent atrial fibrillation (AFib), one of the world’s most prevalent cardiac rhythm disorders.

Sphere-360™ Demonstrates Safety, Efficiency, and Superior Mapping Integration

The Sphere-360 catheter, part of the Affera ecosystem, is engineered as a single-shot PFA mapping and ablation tool designed specifically for paroxysmal AFib. In a European-based, multi-center clinical trial, the technology achieved:

SHERIDAN, WYOMING - May 5, 2025 - In the evolving landscape of restorative dentistry, post-endodontic restoration has emerged as a cornerstone of long-term tooth preservation strategies, offering clinicians and patients alike a pathway to restore function, aesthetics, and durability following root canal therapy. New insights from recent clinical literature highlight the increasing relevance of this specialized restorative approach for practitioners focused on optimizing patient outcomes and return on investment in dental care.

Driving Longevity Through Strategic Restoration

SHERIDAN, WYOMING - May 5, 2025 - In a dental landscape increasingly dominated by minimally invasive approaches, orthognathic surgery-supported by pre- and post-surgical orthodontics-is regaining prominence as a critical solution for addressing complex skeletal deformities that fall beyond the scope of traditional orthodontics.

This resurgent interest is not merely cosmetic. When aesthetic, functional, and long-term stability outcomes are considered, orthognathic surgery emerges as a high-ROI treatment path for select cases. It effectively bridges orthodontic limitations by offering predictable, stable results where skeletal discrepancies compromise both occlusion and facial harmony.

Orthognathic Surgery: A Modern Answer to Structural Challenges

SHERIDAN, WYOMING - May 5, 2025 - The integration of digital technology in dentistry is revolutionizing how dental professionals approach aesthetic treatments, offering enhanced predictability, improved patient engagement, and cross-disciplinary collaboration-while also presenting operational and financial challenges for broader adoption.

Once a futuristic concept, digital dentistry has now become a foundational component in modern dental practices. With advanced software tools like Digital Smile Design (DSD) and the Digital Smile System enabling highly personalized smile simulations, the field is experiencing a strategic shift that enhances both patient outcomes and clinical efficiency.

Transforming Smile Design Through Digital Innovation

SHERIDAN, WYOMING – May 5, 2025 – As dental clinics across the globe continue to strengthen their infection control protocols, the proper use of disinfectants remains a cornerstone of safety. While these products play a pivotal role in preventing cross-infections, recent analyses underscore the need for heightened awareness of the associated chemical and biological risks—making the responsible use of dental disinfectants a strategic imperative for operational safety and compliance.

Balancing Infection Control with Occupational Safety

Cross-infection continues to rank among the most serious complications in healthcare settings, impacting up to 10% of hospitalized patients and generating a staggering annual cost of approximately $4.5 billion in the United States. Though precise figures for dental environments remain difficult to quantify, the threat is real—extending from patients to staff and even external technicians.

SHERIDAN, WYOMING – May 5, 2025 – Ecosite Elements, a leading composite restorative solution, has been prominently featured in the May 2025 issue of Inside Dentistry, spotlighting its clinical effectiveness through a comprehensive case report authored by Dr. Jeff Lineberry. The report highlights a 32-year-old patient presenting with multiple anterior tooth fractures, successfully treated using Ecosite Elements for a highly esthetic and functional outcome.

This feature underscores Ecosite Elements’ growing reputation among dental professionals as a go-to choice for restorative excellence. With a focus on esthetics, efficiency, and material adaptability, the case study demonstrates how modern composite technologies are transforming chairside outcomes and supporting better long-term patient care.

Clinical Precision and Esthetic Performance

SHERIDAN, WYOMING – May 5, 2025 – Dental professionals seeking to enhance their clinical expertise in micro-invasive treatments can now register for a complimentary continuing education (CE) webinar titled “Mastering Resin Infiltration for Predictable Results”, hosted by industry leader Irene Iancu, BSc, RRDH, CTDP, OM. The session, scheduled for June 17, 2025, at 7PM ET, offers one CE credit and delivers a strategic deep dive into the resin infiltration technique using DMG’s Icon system.

Enhancing Practice Outcomes Through Resin Infiltration

Resin infiltration has emerged as a game-changing alternative in the conservative treatment of early carious lesions, providing dentists and hygienists with an advanced, esthetically favorable approach. This CE webinar is designed to help professionals incorporate this micro-invasive procedure into their clinical workflow with confidence and predictability.

SHERIDAN, WYOMING – May 5, 2025 – Shofu’s EyeSpecial C-II Digital Dental Camera has been named the 2014 Best New Product for Women by the American Association of Women Dentists (AAWD), marking a strategic milestone in dental imaging technology and its alignment with the evolving needs of modern dental practices. Recognized at AAWD’s Annual Meeting, themed “Leading the Future of Dentistry”, the camera stood out for its blend of ergonomic design, clinical functionality, and user-focused features—particularly appealing to women dentists and their patients.

Purpose-Built for Dental Professionals

SHERIDAN, WYOMING – May 5, 2025 – Shofu Dental Corporation has unveiled its new Attachment Removal Kit for Clear Aligners, offering dental professionals a complete, minimally invasive solution for safely removing orthodontic attachments while preserving enamel integrity—addressing a critical challenge in clear aligner therapy.

With the continued growth of clear aligner systems such as Invisalign across the global orthodontic market, practitioners are seeking tools that balance clinical efficiency with patient comfort and safety. Shofu’s new kit delivers precisely that, streamlining a procedure often marked by concerns over enamel damage, chairside time, and patient discomfort.

A Strategic Leap in Clear Aligner Care

SHERIDAN, WYOMING – May 5, 2025 – Carestream Dental is setting a new benchmark in digital dental technology with the debut of its latest solutions at the 2025 Chicago Dental Society Midwinter Meeting, including the Advance Edition of the CS 8200 3D system, a next-generation implant planning service, and AI-powered software integrations. These innovations reflect the company’s ongoing commitment to empowering dental professionals with tools that drive operational efficiency, precision, and confidence in care delivery.

Expanded CBCT Capabilities with the CS 8200 3D Advance Edition

A focal point of Carestream Dental’s announcement is the Advance Edition of the CS 8200 3D, a powerful evolution of the award-winning CS 8200 3D Family. Engineered for versatility and scalability, the Advance Edition introduces extended fields of view (FOVs) and advanced artificial intelligence functionalities that cater to a wide spectrum of clinical needs.

SHERIDAN, WYOMING - May 5, 2025 - Endodontic professionals seeking to elevate treatment efficacy and predictability are turning their attention to BioRoot Flow, a next-generation bioactive root canal sealer gaining widespread traction across global dental practices. In a recent expert-led webinar, leading clinicians showcased BioRoot Flow's clinical advantages, emphasizing its long-term success rate, superior biocompatibility, and ease of application-all critical factors in today's competitive dental landscape.

Revolutionizing Root Canal Treatment with BioRoot Flow

Backed by advanced tricalcium silicate chemistry, BioRoot Flow is positioned as a transformative innovation in the field of endodontics. Unlike conventional sealers, its bioactive formula promotes healing and provides excellent sealing capabilities with minimal technique sensitivity.

SHERIDAN, WYOMING - May 5, 2025 - A new interactive webinar is making waves in the dental healthcare industry by spotlighting the clinical and operational advantages of buffering local anesthetic solutions with sodium bicarbonate. Designed for dental professionals, the program explores a practice that may significantly improve patient comfort, accelerate treatment time, and enhance procedural outcomes.

Empowering Dental Professionals Through Evidence-Based Practices

This educational initiative centers on the pharmacology of commercially available local anesthetics and the common challenges practitioners face during administration. By introducing the concept of buffering-modifying anesthetic pH levels just prior to injection using sodium bicarbonate-the webinar equips clinicians with actionable strategies to mitigate pain and reduce onset time.

Participants will gain a deeper understanding of:

SHERIDAN, WYOMING - May 5, 2025 - In observance of National Children's Dental Health Month, Colgate-Palmolive is reinforcing its long-term commitment to children's wellness by spotlighting the profound impact of oral health on overall physical and mental well-being. Through research, education, and advocacy, the company is advancing its vision of a healthier future by promoting accessible oral care habits and resources for families around the world.

A Strategic Focus on Early Intervention and Education

Colgate's global initiative during February aligns with a wider industry shift toward preventative care and early health intervention. According to a recent company-led study surveying over 20,000 parents across 12 countries-including 1,800 U.S. respondents-62% of American children reportedly suffer from cavities, confirming dental decay as the most common disease affecting children in the United States.

SHERIDAN, WYOMING – May 5, 2025 – Colgate-Palmolive is reaffirming its commitment to whole-body health by promoting five daily wellness habits supported by its expansive, science-backed product portfolio. With a strategic focus on preventive care, personal well-being, and responsible pet health, the company continues to drive positive health outcomes at home and in the marketplace.

This initiative highlights how small, intentional habits can create a significant impact on individual wellness—while also positioning Colgate-Palmolive as a global leader in sustainable health solutions. Through educational campaigns, trusted partnerships, and product innovation, the company connects lifestyle practices with measurable health benefits, addressing the rising demand for holistic care across consumer segments.

Prioritizing Oral Health for Total Wellness